Company Canadian Farmaceuticals Srl with Fiscal Code 27427829
recorded a turnover of 2024 of
2.365.842,
with a net profit of
334.243
and having an average number of employees of
9.
The company operates in the field of Intermedieri în comerţul cu produse diverse having the NACE code 4619.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Canadian Farmaceuticals Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
545.335
402.166
1.021.097
931.090
721.478
985.297
1.438.654
1.707.265
1.944.189
2.365.842
Total Income - EUR
545.947
403.764
1.042.026
952.140
721.831
989.954
1.455.722
1.750.416
1.990.776
2.387.748
Total Expenses - EUR
492.689
401.913
884.733
893.318
736.135
770.498
1.020.884
1.389.678
1.651.008
1.988.448
Gross Profit/Loss - EUR
53.258
1.851
157.293
58.822
-14.304
219.456
434.839
360.738
339.769
399.300
Net Profit/Loss - EUR
40.850
-1.815
144.052
46.307
-21.351
211.676
409.307
301.832
290.855
334.243
Employees
6
6
8
9
9
8
11
10
9
9
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 22.4%, from 1.944.189 euro in the year 2023, to 2.365.842 euro in 2024.
The Net Profit increased by 45.014 euro, from 290.855 euro in 2023, to 334.243 in the last year.
Check the financial reports for the company - Canadian Farmaceuticals Srl
Financial Rating - CANADIAN FARMACEUTICALS SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Canadian Farmaceuticals Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Canadian Farmaceuticals Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Canadian Farmaceuticals Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Canadian Farmaceuticals Srl - CUI 27427829
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
67.661
46.718
158.991
386.186
346.229
492.485
664.975
1.231.281
1.539.599
1.781.031
Current Assets
67.970
43.748
216.324
137.728
102.024
105.223
200.106
241.501
150.241
190.266
Inventories
22.162
17.552
52.017
29.014
22.965
65.665
104.027
292.687
239.005
249.461
Receivables
39.753
20.545
95.529
91.833
73.811
67.626
81.121
74.826
148.505
215.095
Cash
6.055
5.651
68.778
16.881
5.248
-28.068
14.958
-126.013
-237.269
-274.290
Shareholders Funds
38.249
35.016
178.475
221.506
195.867
403.828
749.688
986.445
1.274.309
1.438.053
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
90.987
56.233
199.507
303.549
253.090
194.384
116.339
486.815
413.453
531.393
Income in Advance
6.749
0
0
0
0
0
0
0
2.199
1.859
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4619 - 4619"
CAEN Financial Year
4619
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
190.266 euro in 2024 which includes Inventories of
249.461 euro, Receivables of
215.095 euro and cash availability of
-274.290 euro.
The company's Equity was valued at
1.438.053 euro, while total Liabilities amounted to
531.393 euro.
Equity increased by 170.866 euro, from 1.274.309 euro in 2023, to 1.438.053 in 2024.
The Debt Ratio was 27.0% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Canadian Farmaceuticals Srl